Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...

"UK regulators seize illegal weight loss drugs amid global pricing shake-up" was originally created and published by ...

Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

Eli Lilly ( NYSE: LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in ...

Under the agreement, Eli Lilly will continue to market tirzepatide under brand name Mounjaro, while Cipla will have the ...

Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting ...

The United Kingdom's healthcare regulator on Friday said it had made the world's largest seizure of illegal weight loss ...

Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...

Analysts believe that while the deal is positive, Cipla's share price is unlikely to see a fresh run-up, given the rise it ...